MENU
Advertisement
Show Filters
Refine by Content Type
Refine by Year
Sort By:
Choose Sites to Search:
Endovascular Treatment of Iliocaval DVT
A new therapeutic approach using an aspiration cannula and circuit.
By Ripal T. Gandhi, MD; David Quintana, MD; Melanie Schernthaner, MD; Constantino Peña, MD; Andrew Hall, MD; Niberto Moreno, MD; James F. Benenati, MD; and Barry T. Katzen, MD
Bentley Acquires Qmedics and Plans IPO
April 21, 2023—Bentley InnoMed GmbH, headquartered in Hechingen, Germany, announced three significant developments: the company has bought its main supplier, Qmedics AG; it plans to go public under a new Swedish holding company; and it is initiating an incentive program to make its employees shareholders of the new company.
The Roles of Open and Endovascular Repair in Aortic Infection
A review of the approach to treatment for primary and secondary aortic infections.
By Anders Wanhainen, MD, PhD; Karl Sörelius, MD, PhD; Hamid Gavali; and Kevin Mani, MD, PhD
Endologix Launches Alto Abdominal Stent Graft System Outside of the United States
September 2, 2020—Endologix, Inc. announced the first commercial implant of its Alto abdominal stent graft system outside of the United States.
International Trial Begins for the Endologix Ventana Stent Graft
November 2, 2010—Endologix, Inc. (Irvine, CA) announced the first clinical implant of the company's Ventana fenestrated stent graft, which was the first case in the pilot study of this endovascular platform.
First Patients Treated With Endologix's Investigational Ovation Alto EVAR System for Complex AAAs
August 17, 2016—Endologix, Inc. announced that the first two patients have been treated with the investigational Ovation Alto abdominal stent graft system, which is designed for the endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms (AAAs).
Endologix's Next-Generation Nellix EVAS System Approved in Europe
April 11, 2016—Endologix, Inc. announced that the company’s next-generation Nellix endovascular aneurysm sealing (EVAS) received European CE Mark approval system for the treatment of aortic abdominal aneurysm (AAA).
First Patient Enrollment in Shape Memory Medical AAA-SHAPE Study
September 16, 2020—Shape Memory Medical Inc. announced the initiation of the company’s AAA-SHAPE prospective safety study of the Impede-FX embolization plug device when used for abdominal aortic aneurysm (AAA) sac filling during elective endovascular aneurysm repair (EVAR).
Lombard Medical Announces First-in-Man Procedure with IntelliFlex LP Delivery System for Aorfix Stent Graft
November 12, 2015—Lombard Medical, Inc. announced the successful outcome of the first-in-man clinical case using its new IntelliFlex LP low-profile delivery system to deploy the company’s Aorfix endovascular stent graft for the endovascular repair of abdominal aortic aneurysms.
An Interview With Andrew Holden, MBChB, FRANZCR, EBIR
Dr. Holden reflects on the legacy of paclitaxel and lessons learned from the controversy, research priorities for 2022, his philosophy for choosing which projects to accept, and more.
CE Mark Granted for Lombard Medical's IntelliFlex LP Delivery System for the Aorfix EVAR Device
June 21, 2016—Lombard Medical, Inc. announced that it has received CE Mark approval for its IntelliFlex low-profile (LP) delivery system for the Aorfix stent graft for endovascular repair of abdominal aortic aneurysms (AAA).
Lifeline Registry Update: Expansion to an Outcomes Registry
An overview of the progress to date and expanding initiatives for the near future.
By SVS/AVA Outcomes Registry Steering Committee
ESCAPE and EXTEND-IA Trials Confirm Benefits of Medtronic's Solitaire Flow Restoration Device for Stroke
February 11, 2015—Medtronic, plc announced that two studies presented at the International Stroke Conference in Nashville, Tennessee, and published online in The New England Journal of Medicine found that stent thrombectomy using the company’s Solitaire device added to the current standard of pharmaceutical treatment with intravenous tissue plasminogen activator (IV-tPA) significantly reduced disability in patients experiencing a stroke. Both the ESCAPE (Endovascular Treatment for Small Core and Proximal Occlusion Ischemic Stroke) and the EXTEND-IA (Extending the Time for Thrombolysis in Emergency Neurological Deficits—Intra-Arterial) trials were investigator-initiated trials supported by an unrestricted grant from Medtronic that primarily assessed the addition of the company’s Solitaire device in conjunction with IV-tPA.
Complications of Renal Artery Stenting
Diagnosis and management of stent malposition and antegrade arterial dissection.
By Andrew Holden, MBChB, FRANZCR
Treating Postpartum Hemorrhage and Invasive Placenta
Endovascular techniques to improve outcomes in patients with abnormal invasive placenta.
By Andrew C. Picel, MD; Rory L. Cochran, PhD; and Kari J. Nelson, MD
Below-the-Knee Drug-Eluting Stents
Is there a role for this readily available device in treating critical limb ischemia?
By Andrew J. Feiring, MD, FACC, FSCAI
Combining Embolic Protection and the No-Touch Technique
How a combination of two techniques can be used for successful and safe renal artery revascularization.
Embolic Protection Devices in RAS
The use of a distal embolic protection device can significantly improve results after stent revascularization for patients with ischemic nephropathy.
By Andrew Holden, MBCHB, FRANZCR
Yttrium-90 Radioembolization
Recent advances in hepatic embolotherapy.
By David M. Liu, MD, FRCP(C); David N. Cade, MD; Jesse Knight, MD; Rodney Raabe, MD; Stephen Kee, MD; Andrew Kennedy, MD, FACRO; and Riad Salem, MD, FSIR, MBA
Uterine Fibroid Embolization in a Patient With Lupus and Previous VTE
Moderator: Kari J. Nelson, MDPanel: Maureen P. Kohi, MD, FSIR; Andrew C. Picel, MD; and E. Brooke Spencer, MD, FSIR
